Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Hamilton Thorne Ltd V.HTL


Primary Symbol: T.HTL Alternate Symbol(s):  HTLZF

Hamilton Thorne Ltd. is a provider of precision instruments, consumables, software and services to assisted reproductive technologies (ART), research, and cell biology markets. The Company markets its products and services under the Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, Microptic, and Embryotech Laboratories brands. It also provides an array of third-party equipment and consumables to meet customer requirements. Its branded instrument, equipment and software product lines include precision laser devices, imaging systems, incubators, laminar flow workstations, air purification systems, control rate freezers, lab monitoring systems, and micromanipulation systems. It also offers a portfolio of artificial intelligence (AI)-enabled common astronomy software applications (CASA) software and other product offerings. Its GM501 family of products provides the in vitro fertilization (IVF) lab with comprehensive cell culture media solutions.


TSX:HTL - Post by User

Comment by dogatcaton Aug 01, 2022 3:19am
112 Views
Post# 34863727

RE:RE:RE:Buying all along

RE:RE:RE:Buying all along New Issue July 18, 2022 Hamilton Thorne Ltd. $120,000,000 Common Shares Preferred Shares Warrants Units Subscription Receipts Debt Securities This short form base shelf prospectus (“Prospectus”) relates to the offering for sale by Hamilton Thorne Ltd. (“Hamilton Thorne” or the “Corporation”) from time to time, during the 25-month period that this Prospectus, including any amendments thereto, remains valid, of up to $120,000,000 in the aggregate of: (i) common shares (“Common Shares”) in the capital of the Corporation; (ii) preferred shares (“Preferred Shares”) in the capital of the Corporation; (iii) warrants (“Warrants”) to purchase other Securities (as defined below) of Hamilton Thorne; (iv) units (“Units”) comprising of one or more of the other Securities; (v) subscription receipts (“Subscription Receipts”); and (vi) debt securities of the Corporation (the “Debt Securities” and together with the Common Shares, Preferred Shares, Warrants, Units and Subscription Receipts, collectively referred to herein as the “Securities”). The Securities may be offered separately or together, in amounts, at prices and on terms determined based on market conditions at the time of the sale and as set forth in an accompanying prospectus supplement (a “Prospectus Supplement”).
<< Previous
Bullboard Posts
Next >>